Episurf Medical Q1 2025: Solid start of 2025 - Redeye

Redeye provides an in-depth review of Episurf Medical’s Q1 report and events during and after the quarter. The report contained no significant surprises, and the financials were largely in line with our estimates. We reiterate our fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/1094702/episurf-medical-q1-2025-solid-start-of-2025?utm_source=finwire&utm_medium=RSS